US9182398B2 - Methods and compositions for detecting fungi and mycotoxins - Google Patents
Methods and compositions for detecting fungi and mycotoxins Download PDFInfo
- Publication number
- US9182398B2 US9182398B2 US11/731,674 US73167407A US9182398B2 US 9182398 B2 US9182398 B2 US 9182398B2 US 73167407 A US73167407 A US 73167407A US 9182398 B2 US9182398 B2 US 9182398B2
- Authority
- US
- United States
- Prior art keywords
- seq
- mycotoxin
- patient
- primer
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000002636 mycotoxin Substances 0.000 title claims abstract description 165
- 231100000678 Mycotoxin Toxicity 0.000 title claims abstract description 163
- 238000000034 method Methods 0.000 title claims abstract description 93
- 239000000203 mixture Substances 0.000 title description 32
- 241000233866 Fungi Species 0.000 title description 17
- 210000001124 body fluid Anatomy 0.000 claims abstract description 60
- 239000010839 body fluid Substances 0.000 claims abstract description 60
- 206010017533 Fungal infection Diseases 0.000 claims abstract description 20
- 208000031888 Mycoses Diseases 0.000 claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 17
- 201000010099 disease Diseases 0.000 claims abstract description 16
- 238000011269 treatment regimen Methods 0.000 claims abstract description 3
- 239000005409 aflatoxin Substances 0.000 claims description 45
- 229930195730 Aflatoxin Natural products 0.000 claims description 43
- 238000001514 detection method Methods 0.000 claims description 39
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 230000028327 secretion Effects 0.000 claims description 19
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 18
- 229930183344 ochratoxin Natural products 0.000 claims description 18
- 210000002700 urine Anatomy 0.000 claims description 17
- 239000013642 negative control Substances 0.000 claims description 12
- 238000001574 biopsy Methods 0.000 claims description 9
- 239000013641 positive control Substances 0.000 claims description 8
- 206010036790 Productive cough Diseases 0.000 claims description 7
- 239000012188 paraffin wax Substances 0.000 claims description 7
- 210000003802 sputum Anatomy 0.000 claims description 7
- 208000024794 sputum Diseases 0.000 claims description 7
- 230000035945 sensitivity Effects 0.000 claims description 5
- 238000002965 ELISA Methods 0.000 claims description 3
- 239000000523 sample Substances 0.000 abstract description 184
- 230000002538 fungal effect Effects 0.000 abstract description 51
- 210000001519 tissue Anatomy 0.000 description 92
- 239000011324 bead Substances 0.000 description 47
- 239000004005 microsphere Substances 0.000 description 44
- 108020004414 DNA Proteins 0.000 description 40
- 238000003556 assay Methods 0.000 description 39
- 108020000949 Fungal DNA Proteins 0.000 description 34
- 239000000427 antigen Substances 0.000 description 31
- 108091007433 antigens Proteins 0.000 description 31
- 102000036639 antigens Human genes 0.000 description 31
- 150000007523 nucleic acids Chemical class 0.000 description 31
- 241000894007 species Species 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 108020004707 nucleic acids Proteins 0.000 description 30
- 102000039446 nucleic acids Human genes 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 238000012360 testing method Methods 0.000 description 27
- 229910001868 water Inorganic materials 0.000 description 26
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- 239000002953 phosphate buffered saline Substances 0.000 description 19
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 18
- 238000000605 extraction Methods 0.000 description 18
- 241000228212 Aspergillus Species 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000011521 glass Substances 0.000 description 15
- 241000228143 Penicillium Species 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 238000003199 nucleic acid amplification method Methods 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 description 13
- 230000000295 complement effect Effects 0.000 description 13
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 description 13
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- IMUQLZLGWJSVMV-UOBFQKKOSA-N roridin A Natural products CC(O)C1OCCC(C)C(O)C(=O)OCC2CC(=CC3OC4CC(OC(=O)C=C/C=C/1)C(C)(C23)C45CO5)C IMUQLZLGWJSVMV-UOBFQKKOSA-N 0.000 description 12
- 229930013292 trichothecene Natural products 0.000 description 12
- 150000003327 trichothecene derivatives Chemical class 0.000 description 12
- 239000000872 buffer Substances 0.000 description 11
- 230000008878 coupling Effects 0.000 description 11
- 238000010168 coupling process Methods 0.000 description 11
- 238000005859 coupling reaction Methods 0.000 description 11
- 241000223218 Fusarium Species 0.000 description 10
- NSFWWJIQIKBZMJ-YKNYLIOZSA-N Roridin A Chemical compound C([C@]12[C@]3(C)[C@H]4C[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)[C@@H](O)[C@H](C)CCO[C@H](\C=C\C=C/C(=O)O4)[C@H](O)C)O2 NSFWWJIQIKBZMJ-YKNYLIOZSA-N 0.000 description 10
- 241001279361 Stachybotrys Species 0.000 description 10
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 description 10
- 229930002954 deoxynivalenol Natural products 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 229910001629 magnesium chloride Inorganic materials 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 241000228245 Aspergillus niger Species 0.000 description 8
- 241000203233 Aspergillus versicolor Species 0.000 description 8
- 238000009739 binding Methods 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 238000003753 real-time PCR Methods 0.000 description 8
- 238000003757 reverse transcription PCR Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 108700012359 toxins Proteins 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 238000011888 autopsy Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 5
- SJCPVUVBUQDGKN-RDSLEMPWSA-N 53126-10-6 Chemical compound C12([C@]3(C)[C@H]4C[C@H]2O[C@@H]2C=C(C)CC[C@@]23COC(=O)C2OC22CCOC(/C=C\C=C/C(=O)O4)(C2O)C(=O)C)CO1 SJCPVUVBUQDGKN-RDSLEMPWSA-N 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 241000427940 Fusarium solani Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- KEEQQEKLEZRLDS-BTSIIUDZSA-N Isororidin E Natural products CC(O)C1OCCC(=CC(=O)OCC23CCC(=CC2OC4CC(OC(=O)C=C/C=C/1)C3(C)C45CO5)C)C KEEQQEKLEZRLDS-BTSIIUDZSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 241001494479 Pecora Species 0.000 description 5
- 241001279364 Stachybotrys chartarum Species 0.000 description 5
- 239000002115 aflatoxin B1 Substances 0.000 description 5
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 5
- 229930020125 aflatoxin-B1 Natural products 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 239000013610 patient sample Substances 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- FIEWYRUUMFMNTA-NMRGUGIHSA-N roridin E Natural products CC(O)C1OCCC=C/C(=O)OC23CCC(=CC2CC4CC(CC(=O)C=C/C=C/1)C3(C)C45CO5)C FIEWYRUUMFMNTA-NMRGUGIHSA-N 0.000 description 5
- KEEQQEKLEZRLDS-FLGSVKSYSA-N roridin e Chemical compound C([C@@]12[C@]3(C)[C@H]4C[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)/C=C(C)/CCO[C@H](\C=C\C=C/C(=O)O4)[C@H](O)C)O2 KEEQQEKLEZRLDS-FLGSVKSYSA-N 0.000 description 5
- 229930194532 satratoxin Natural products 0.000 description 5
- GTONGKBINDTWOM-QXMOYCCXSA-N satratoxin g Chemical compound O1C(=O)\C=C/C=C/C(C(O)C)(C2O)OCCC32OC3C(=O)OCC23CCC(C)=CC2OC2CC1C3(C)C21CO1 GTONGKBINDTWOM-QXMOYCCXSA-N 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- 229930132918 Aflatoxin B2 Natural products 0.000 description 4
- 241000228197 Aspergillus flavus Species 0.000 description 4
- 241000122818 Aspergillus ustus Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- ZSRVBNXAPSQDFY-UHFFFAOYSA-N Mycobactin P Natural products OCC12CCC(C)=CC1OC1CC(O)C2(C)C11CO1 ZSRVBNXAPSQDFY-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- JGIYRVDWRBKREW-UHFFFAOYSA-N Roridin L2 Natural products C1C(C23OC3)OC3C=C(C)CCC3(CO)C2(C)C1OC(=O)C=CC=CC(C(O)C)OCCC1=CC(=O)OC1 JGIYRVDWRBKREW-UHFFFAOYSA-N 0.000 description 4
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 4
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 239000002097 aflatoxin B2 Substances 0.000 description 4
- WWSYXEZEXMQWHT-WNWIJWBNSA-N aflatoxin B2 Chemical compound C=1([C@@H]2CCO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O WWSYXEZEXMQWHT-WNWIJWBNSA-N 0.000 description 4
- ZSRVBNXAPSQDFY-OJVARPOJSA-N chembl504718 Chemical compound C([C@@]12[C@@]3([C@H](O)C[C@H]1O[C@@H]1C=C(CC[C@@]13CO)C)C)O2 ZSRVBNXAPSQDFY-OJVARPOJSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- IWFOIUWPNYEUAI-DGKUEWFHSA-N roridin H Natural products CC1OC2CC(=C/C(=O)OCC34CCC(=CC3OC5CC(OC(=O)C=C/C=C/C1O2)C4(C)C56CO6)C)C IWFOIUWPNYEUAI-DGKUEWFHSA-N 0.000 description 4
- IWFOIUWPNYEUAI-WUCVSPPTSA-N roridin h Chemical compound C([C@@]12[C@]3(C)[C@H]4C[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)/C=C(C)/C[C@@H]1O[C@@H]([C@@H](\C=C\C=C/C(=O)O4)O1)C)O2 IWFOIUWPNYEUAI-WUCVSPPTSA-N 0.000 description 4
- QJTYSASOTORSFG-LEMRECQJSA-N roridin l-2 Chemical compound O([C@H]1[C@]2(C)[C@@]3(CO)CCC(C)=C[C@H]3O[C@@H]([C@]22OC2)C1)C(=O)\C=C\C=C/C(C(O)C)OCCC1=CCOC1=O QJTYSASOTORSFG-LEMRECQJSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229930063498 Aflatoxin G1 Natural products 0.000 description 3
- XWIYFDMXXLINPU-WNWIJWBNSA-N Aflatoxin G1 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1C=CO[C@@H]1O2 XWIYFDMXXLINPU-WNWIJWBNSA-N 0.000 description 3
- 229930166256 Aflatoxin G2 Natural products 0.000 description 3
- WPCVRWVBBXIRMA-WNWIJWBNSA-N Aflatoxin G2 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1CCO[C@@H]1O2 WPCVRWVBBXIRMA-WNWIJWBNSA-N 0.000 description 3
- 241000122824 Aspergillus ochraceus Species 0.000 description 3
- 241001277988 Aspergillus sydowii Species 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000228150 Penicillium chrysogenum Species 0.000 description 3
- 241001219053 Penicillium fellutanum Species 0.000 description 3
- 241000228129 Penicillium janthinellum Species 0.000 description 3
- 241000864266 Penicillium verrucosum Species 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000002098 aflatoxin G1 Substances 0.000 description 3
- 239000002100 aflatoxin G2 Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 210000003027 ear inner Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- -1 tricothecenes Substances 0.000 description 3
- 229930190906 verrucarin Natural products 0.000 description 3
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 241000228218 Aspergillus amstelodami Species 0.000 description 2
- 241001225321 Aspergillus fumigatus Species 0.000 description 2
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- 241000228230 Aspergillus parasiticus Species 0.000 description 2
- 206010003571 Astrocytoma Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000035904 Exposure to mould Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000453701 Galactomyces candidum Species 0.000 description 2
- 241001598067 Memnoniella echinata Species 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 101100286668 Mus musculus Irak1bp1 gene Proteins 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001507683 Penicillium aurantiogriseum Species 0.000 description 2
- 241000228153 Penicillium citrinum Species 0.000 description 2
- 241001223091 Penicillium corylophilum Species 0.000 description 2
- 241001507662 Penicillium crustosum Species 0.000 description 2
- 241000864270 Penicillium echinulatum Species 0.000 description 2
- 241001123663 Penicillium expansum Species 0.000 description 2
- 241001507686 Penicillium gladioli Species 0.000 description 2
- 241001507804 Penicillium hirsutum Species 0.000 description 2
- 240000000064 Penicillium roqueforti Species 0.000 description 2
- 241000235527 Rhizopus Species 0.000 description 2
- HISRAYIPWNHFKY-JDVXGTLTSA-N Satratoxin G Natural products CC(O)C12OCCC3(OC3C(=O)OCC4CCCC5OC6CC(OC(=O)C=C/C=C/1)C(C)(C45)C67CO7)C2O HISRAYIPWNHFKY-JDVXGTLTSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- UDLWSISPUSEJTG-UHFFFAOYSA-N Verrucarin A Natural products CC1CCOC(=O)C=CCCC(=O)OC2CC3OC4C=C(C)CCC4(COC(=O)C1O)C2(C)C35CO5 UDLWSISPUSEJTG-UHFFFAOYSA-N 0.000 description 2
- GXCGYHWSYNQVHU-UEWFSQRBSA-N Verrucarin J Natural products CC1=CC2OC3CC4OC(=O)C=C/C=C/C(=O)OCCC(=C/C(=O)OCC2(CC1)C4(C)C35CO5)C GXCGYHWSYNQVHU-UEWFSQRBSA-N 0.000 description 2
- GXCGYHWSYNQVHU-GYDJLPFWSA-N Verrucarin j Chemical compound C([C@@]12[C@@]3(C)[C@]45COC(=O)/C=C(C)/CCOC(=O)\C=C\C=C/C(=O)O[C@@H]3C[C@H]1O[C@@H]4C=C(CC5)C)O2 GXCGYHWSYNQVHU-GYDJLPFWSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 238000002967 competitive immunoassay Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000013024 dilution buffer Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000005497 microtitration Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- MUACSCLQRGEGOE-JOBFPFSDSA-N satratoxin H Natural products CC(O)C12OCCC(=C/C(=O)OCC34CCC(=CC3OC5CC(OC(=O)C=C/C=C/1)C4(C)C56CO6)C)C2O MUACSCLQRGEGOE-JOBFPFSDSA-N 0.000 description 2
- MUACSCLQRGEGOE-RXLTUBJDSA-N satratoxin h Chemical compound C([C@@]12[C@]3(C)[C@H]4C[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)C=C1CCO[C@@](/C=C/C=C/C(=O)O4)(C1O)[C@@H](O)C)O2 MUACSCLQRGEGOE-RXLTUBJDSA-N 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 238000007390 skin biopsy Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 231100000033 toxigenic Toxicity 0.000 description 2
- 230000001551 toxigenic effect Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- NLUGUZJQJYVUHS-IDXDZYHTSA-N verrucarin A Chemical compound C([C@@]12[C@@]3(C)[C@@]45CCC(C)=C[C@H]4O[C@@H]1C[C@H]3OC(=O)\C=C/C=C/C(=O)OCC[C@H]([C@@H](C(=O)OC5)O)C)O2 NLUGUZJQJYVUHS-IDXDZYHTSA-N 0.000 description 2
- NLUGUZJQJYVUHS-UHFFFAOYSA-N verrucarina A Natural products C1OC(=O)C(O)C(C)CCOC(=O)C=CC=CC(=O)OC2CC3OC4C=C(C)CCC41C2(C)C31CO1 NLUGUZJQJYVUHS-UHFFFAOYSA-N 0.000 description 2
- XZIDTOHMJBOSOX-UHFFFAOYSA-N 2,3,6-TBA Chemical compound OC(=O)C1=C(Cl)C=CC(Cl)=C1Cl XZIDTOHMJBOSOX-UHFFFAOYSA-N 0.000 description 1
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- JRUMBKYTDKXCJC-MGPLVRAMSA-N 3-[(3ar,8bs)-8-hydroxy-6-methoxy-3a,8b-dihydrofuro[2,3-b][1]benzofuran-7-yl]cyclopent-2-en-1-one Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C1OC)C(O)=C1C1=CC(=O)CC1 JRUMBKYTDKXCJC-MGPLVRAMSA-N 0.000 description 1
- 241000293029 Absidia caerulea Species 0.000 description 1
- 241000235390 Absidia glauca Species 0.000 description 1
- 241001103808 Albifimbria verrucaria Species 0.000 description 1
- 241000223602 Alternaria alternata Species 0.000 description 1
- 241000266325 Alternaria atra Species 0.000 description 1
- 241000266326 Alternaria botrytis Species 0.000 description 1
- 241000266330 Alternaria chartarum Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 241000293034 Apophysomyces elegans Species 0.000 description 1
- 241000981384 Aspergillus auricomus Species 0.000 description 1
- 241001065417 Aspergillus chevalieri Species 0.000 description 1
- 241000134919 Aspergillus conicus Species 0.000 description 1
- 241000892910 Aspergillus foetidus Species 0.000 description 1
- 241000132177 Aspergillus glaucus Species 0.000 description 1
- 241000131308 Aspergillus nomius Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000981402 Aspergillus ostianus Species 0.000 description 1
- 241000374462 Aspergillus pseudoglaucus Species 0.000 description 1
- 241000228254 Aspergillus restrictus Species 0.000 description 1
- 241000914343 Aspergillus ruber Species 0.000 description 1
- 241000133685 Aspergillus rugulosus Species 0.000 description 1
- 241000131386 Aspergillus sojae Species 0.000 description 1
- 241000134719 Aspergillus tamarii Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000079253 Byssochlamys spectabilis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241001515917 Chaetomium globosum Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241001149955 Cladosporium cladosporioides Species 0.000 description 1
- 241001149956 Cladosporium herbarum Species 0.000 description 1
- 241000320442 Cladosporium sphaerospermum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241001480521 Conidiobolus coronatus Species 0.000 description 1
- 241000293017 Conidiobolus incongruus Species 0.000 description 1
- 241001125840 Coryphaenidae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000235556 Cunninghamella elegans Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000228138 Emericella Species 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000006782 Fusarium chlamydosporum Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000017388 Geotrichum candidum Nutrition 0.000 description 1
- 241000178293 Geotrichum klebahnii Species 0.000 description 1
- 241000282818 Giraffidae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 241000144128 Lichtheimia corymbifera Species 0.000 description 1
- 241000132887 Lomentospora prolificans Species 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001617519 Microascus chartarus Species 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- 241000134403 Mortierella polycephala Species 0.000 description 1
- 241000293022 Mortierella wolfii Species 0.000 description 1
- 241000306281 Mucor ambiguus Species 0.000 description 1
- 241000293033 Mucor amphibiorum Species 0.000 description 1
- 241000907556 Mucor hiemalis Species 0.000 description 1
- 241000908234 Mucor indicus Species 0.000 description 1
- 241001149951 Mucor mucedo Species 0.000 description 1
- 241000235526 Mucor racemosus Species 0.000 description 1
- 241000293032 Mucor ramosissimus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- AWZJFZMWSUBJAJ-UHFFFAOYSA-N OG-514 dye Chemical compound OC(=O)CSC1=C(F)C(F)=C(C(O)=O)C(C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)=C1F AWZJFZMWSUBJAJ-UHFFFAOYSA-N 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 208000005775 Parakeratosis Diseases 0.000 description 1
- 241001099903 Paramyrothecium roridum Species 0.000 description 1
- 241000216869 Penicillium biourgeianum Species 0.000 description 1
- 241000228145 Penicillium brevicompactum Species 0.000 description 1
- 241000228147 Penicillium camemberti Species 0.000 description 1
- 235000002245 Penicillium camembertii Nutrition 0.000 description 1
- 241000985548 Penicillium charlesii Species 0.000 description 1
- 241001507677 Penicillium commune Species 0.000 description 1
- 241001507797 Penicillium coprophilum Species 0.000 description 1
- 241000985535 Penicillium decumbens Species 0.000 description 1
- 241000674481 Penicillium egyptiacum Species 0.000 description 1
- 241000231621 Penicillium freii Species 0.000 description 1
- 241000985530 Penicillium glabrum Species 0.000 description 1
- 241001501993 Penicillium glandicola Species 0.000 description 1
- 241000228127 Penicillium griseofulvum Species 0.000 description 1
- 241000122123 Penicillium italicum Species 0.000 description 1
- 241001444681 Penicillium lapidosum Species 0.000 description 1
- 241000985538 Penicillium madriti Species 0.000 description 1
- 241000985514 Penicillium ochrochloron Species 0.000 description 1
- 241000985513 Penicillium oxalicum Species 0.000 description 1
- 241001219792 Penicillium raperi Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 241001219789 Penicillium sartoryi Species 0.000 description 1
- 241000985511 Penicillium sclerotigenum Species 0.000 description 1
- 241000864268 Penicillium solitum Species 0.000 description 1
- 241000228168 Penicillium sp. Species 0.000 description 1
- 241000909532 Penicillium spinulosum Species 0.000 description 1
- 241000864371 Penicillium viridicatum Species 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000283080 Proboscidea <mammal> Species 0.000 description 1
- 241001465752 Purpureocillium lilacinum Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 201000007981 Reye syndrome Diseases 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000235525 Rhizomucor pusillus Species 0.000 description 1
- 241000293031 Rhizomucor variabilis Species 0.000 description 1
- 241000593344 Rhizopus microsporus Species 0.000 description 1
- 244000205939 Rhizopus oligosporus Species 0.000 description 1
- 235000000471 Rhizopus oligosporus Nutrition 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000228417 Sarocladium strictum Species 0.000 description 1
- 101100412093 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rec16 gene Proteins 0.000 description 1
- 241001114517 Scopulariopsis asperula Species 0.000 description 1
- 241000825258 Scopulariopsis brevicaulis Species 0.000 description 1
- 241000122802 Scopulariopsis brumptii Species 0.000 description 1
- 241001114480 Scopulariopsis fusca Species 0.000 description 1
- 241001501995 Scopulariopsis sphaerospora Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241001460073 Trichoderma asperellum Species 0.000 description 1
- 241000894120 Trichoderma atroviride Species 0.000 description 1
- 241000227728 Trichoderma hamatum Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241000378866 Trichoderma koningii Species 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000601794 Trichothecium Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 241001339189 Wallemia sebi Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 230000007278 cognition impairment Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 208000018883 loss of balance Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003589 nefrotoxic effect Effects 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- VYNDHICBIRRPFP-UHFFFAOYSA-N pacific blue Chemical compound FC1=C(O)C(F)=C2OC(=O)C(C(=O)O)=CC2=C1 VYNDHICBIRRPFP-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940098377 penicillium brevicompactum Drugs 0.000 description 1
- 229940094461 penicillium glabrum Drugs 0.000 description 1
- 210000004912 pericardial fluid Anatomy 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229940016590 sarkosyl Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- JJGWLCLUQNFDIS-GTSONSFRSA-M sodium;1-[6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCCCNC(=O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2CS1 JJGWLCLUQNFDIS-GTSONSFRSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000005353 urine analysis Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000006516 vital cellular process Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/731,674 US9182398B2 (en) | 2006-04-01 | 2007-03-30 | Methods and compositions for detecting fungi and mycotoxins |
US13/669,579 US8628928B2 (en) | 2006-04-01 | 2012-11-06 | Methods and compositions for detecting fungi and mycotoxins |
US13/827,441 US20130183697A1 (en) | 2006-04-01 | 2013-03-14 | Methods And Compositions For Detecting Fungi And Mycotoxins |
US14/256,269 US9103829B2 (en) | 2006-04-01 | 2014-04-18 | Methods and compositions for detecting fungi and mycotoxins |
US14/789,164 US20150337396A1 (en) | 2006-04-01 | 2015-07-01 | Method and compositions for detecting fungi and mycotoxins |
US15/144,016 US10274493B2 (en) | 2006-04-01 | 2016-05-02 | Methods and compositions for detecting fungi and mycotoxins |
US15/635,807 US10036748B2 (en) | 2006-04-01 | 2017-06-28 | Methods and compositions for detecting fungi and mycotoxins |
US16/007,504 US20190101534A1 (en) | 2006-04-01 | 2018-06-13 | Methods and compositions for detecting fungi and mycotoxins |
US16/116,032 US20190101535A1 (en) | 2006-04-01 | 2018-08-29 | Methods and compositions for detecting fungi and mycotoxins |
US16/361,720 US20190277848A1 (en) | 2006-04-01 | 2019-03-22 | Methods and compositions for detecting fungi and mycotoxins |
US18/049,993 US20230194523A1 (en) | 2006-04-01 | 2022-10-26 | Methods and compositions for detecting fungi and mycotoxins |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78775406P | 2006-04-01 | 2006-04-01 | |
US79097406P | 2006-04-11 | 2006-04-11 | |
US11/731,674 US9182398B2 (en) | 2006-04-01 | 2007-03-30 | Methods and compositions for detecting fungi and mycotoxins |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/669,579 Continuation US8628928B2 (en) | 2006-04-01 | 2012-11-06 | Methods and compositions for detecting fungi and mycotoxins |
Publications (2)
Publication Number | Publication Date |
---|---|
US20080014582A1 US20080014582A1 (en) | 2008-01-17 |
US9182398B2 true US9182398B2 (en) | 2015-11-10 |
Family
ID=39325071
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/731,674 Active 2028-11-20 US9182398B2 (en) | 2006-04-01 | 2007-03-30 | Methods and compositions for detecting fungi and mycotoxins |
US13/669,579 Active US8628928B2 (en) | 2006-04-01 | 2012-11-06 | Methods and compositions for detecting fungi and mycotoxins |
US13/827,441 Abandoned US20130183697A1 (en) | 2006-04-01 | 2013-03-14 | Methods And Compositions For Detecting Fungi And Mycotoxins |
US14/256,269 Active US9103829B2 (en) | 2006-04-01 | 2014-04-18 | Methods and compositions for detecting fungi and mycotoxins |
US14/789,164 Abandoned US20150337396A1 (en) | 2006-04-01 | 2015-07-01 | Method and compositions for detecting fungi and mycotoxins |
US15/144,016 Active US10274493B2 (en) | 2006-04-01 | 2016-05-02 | Methods and compositions for detecting fungi and mycotoxins |
US15/635,807 Active US10036748B2 (en) | 2006-04-01 | 2017-06-28 | Methods and compositions for detecting fungi and mycotoxins |
US16/007,504 Abandoned US20190101534A1 (en) | 2006-04-01 | 2018-06-13 | Methods and compositions for detecting fungi and mycotoxins |
US16/116,032 Abandoned US20190101535A1 (en) | 2006-04-01 | 2018-08-29 | Methods and compositions for detecting fungi and mycotoxins |
US16/361,720 Abandoned US20190277848A1 (en) | 2006-04-01 | 2019-03-22 | Methods and compositions for detecting fungi and mycotoxins |
US18/049,993 Pending US20230194523A1 (en) | 2006-04-01 | 2022-10-26 | Methods and compositions for detecting fungi and mycotoxins |
Family Applications After (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/669,579 Active US8628928B2 (en) | 2006-04-01 | 2012-11-06 | Methods and compositions for detecting fungi and mycotoxins |
US13/827,441 Abandoned US20130183697A1 (en) | 2006-04-01 | 2013-03-14 | Methods And Compositions For Detecting Fungi And Mycotoxins |
US14/256,269 Active US9103829B2 (en) | 2006-04-01 | 2014-04-18 | Methods and compositions for detecting fungi and mycotoxins |
US14/789,164 Abandoned US20150337396A1 (en) | 2006-04-01 | 2015-07-01 | Method and compositions for detecting fungi and mycotoxins |
US15/144,016 Active US10274493B2 (en) | 2006-04-01 | 2016-05-02 | Methods and compositions for detecting fungi and mycotoxins |
US15/635,807 Active US10036748B2 (en) | 2006-04-01 | 2017-06-28 | Methods and compositions for detecting fungi and mycotoxins |
US16/007,504 Abandoned US20190101534A1 (en) | 2006-04-01 | 2018-06-13 | Methods and compositions for detecting fungi and mycotoxins |
US16/116,032 Abandoned US20190101535A1 (en) | 2006-04-01 | 2018-08-29 | Methods and compositions for detecting fungi and mycotoxins |
US16/361,720 Abandoned US20190277848A1 (en) | 2006-04-01 | 2019-03-22 | Methods and compositions for detecting fungi and mycotoxins |
US18/049,993 Pending US20230194523A1 (en) | 2006-04-01 | 2022-10-26 | Methods and compositions for detecting fungi and mycotoxins |
Country Status (2)
Country | Link |
---|---|
US (11) | US9182398B2 (fr) |
WO (1) | WO2008051285A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10030278B2 (en) | 2008-08-22 | 2018-07-24 | Advatect Diagnostics, Llc | Methods and compositions for identifying yeast |
US10036748B2 (en) | 2006-04-01 | 2018-07-31 | Advatect Diagnostics, Llc | Methods and compositions for detecting fungi and mycotoxins |
US10443106B2 (en) | 2009-10-08 | 2019-10-15 | Advatect Diagnostics, Llc | Methods and compositions for identifying sulfur and iron modifying bacteria |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075322A1 (en) * | 2008-08-22 | 2010-03-25 | Hooper Dennis G | Methods and Compositions for Identifying Mycotoxins and Fungal Species |
EP2465945A1 (fr) * | 2010-12-17 | 2012-06-20 | F. Hoffmann-La Roche AG | Matrice générique pour acides nucléiques de contrôle |
ITMO20110109A1 (it) * | 2011-05-11 | 2012-11-12 | Generon S R L | Metodo per l'analisi di aflatossine nel latte e nei derivati del latte |
US8956821B2 (en) | 2013-02-06 | 2015-02-17 | Medical Service Consultation International, Llc | Methods and compositions for detecting Aspergillus terreus, Aspergillus niger, and mycotoxins |
US9658136B2 (en) * | 2014-04-18 | 2017-05-23 | Sue Price | Mycotoxin sample-collecting kit and method |
EP3257951A3 (fr) | 2016-06-17 | 2018-03-14 | AdvaTect Diagnostics, LLC | Procédés et compositions pour identifier et quantifier l'adn fongique |
US20210293813A1 (en) * | 2020-03-18 | 2021-09-23 | Waters Technologies Corporation | High throughput affinity sample preparation for mycotoxin analysis |
CN113293225B (zh) * | 2021-06-29 | 2024-04-02 | 江南大学 | 一种能特异性识别曲霉属、青霉属和镰刀菌属的引物探针组合及其应用 |
CN113684303A (zh) * | 2021-09-09 | 2021-11-23 | 三只松鼠股份有限公司 | 一种用于检测坚果中霉菌的引物组合、试剂盒及坚果中产霉菌毒素真菌种类的检测方法 |
CN117568509A (zh) * | 2023-11-17 | 2024-02-20 | 厦门飞朔生物技术有限公司 | 一种基于微滴数字pcr技术检测曲霉、青霉和镰刀菌的引物探针组合及应用 |
Citations (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4744981A (en) | 1985-10-17 | 1988-05-17 | Neorx Corporation | Trichothecene antibody conjugates |
US4772551A (en) | 1985-12-26 | 1988-09-20 | Neogen Corporation | Method and test kit for detecting a trichothecene using novel monoclonal antibodies |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5261394A (en) | 1991-09-30 | 1993-11-16 | Triangle Research And Development Corporation | Percussive aid for the treatment of chronic lung disease |
US5426027A (en) | 1993-05-20 | 1995-06-20 | The Government Of The United States Of America As Represented By The Secretary | Nucleic acid probes and methods for detecting Candida DNA cells in blood |
WO1996021741A1 (fr) | 1995-01-13 | 1996-07-18 | Chiron Diagnostics Corporation | Sondes d'acide nucleique pour la detection et l'identification de champignons |
US5776694A (en) | 1990-10-19 | 1998-07-07 | Becton Dickinson Company | Diagnostic kits useful for selectively detecting microorganisms in samples |
WO1998050584A2 (fr) | 1997-05-02 | 1998-11-12 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, c/o Centers for Disease Control and Prevention, Technology Transfer Offic | Acides nucleiques pour la detection du genre aspergillus et autres champignons filamenteux |
US6210345B1 (en) | 1999-10-04 | 2001-04-03 | American Biosystems, Inc. | Outcome measuring airway resistance diagnostic system |
US20010004813A1 (en) | 1999-05-28 | 2001-06-28 | Hedman David E. | System and method for removing harmful organic substances from an enclosure |
US6268222B1 (en) | 1998-01-22 | 2001-07-31 | Luminex Corporation | Microparticles attached to nanoparticles labeled with flourescent dye |
WO2001054653A1 (fr) | 2000-01-28 | 2001-08-02 | Merck Patent Gmbh | Formulation galenique |
US6345025B1 (en) | 1993-04-12 | 2002-02-05 | Olympus Optical Co., Ltd. | Apparatus for recording and/or reproducing information and/or from optical information record disk |
US6362008B1 (en) | 1997-12-23 | 2002-03-26 | Barbara A. Kohn | Generic signalling mechanism for detection of analytes |
EP1215282A1 (fr) * | 1999-09-07 | 2002-06-19 | Kyowa Medex Co., Ltd. | Procede de detection de mycotoxines de trichothecene et leur reactif |
US20030054356A1 (en) | 2000-09-21 | 2003-03-20 | Jacobson James W. | Multiple reporter read-out for bioassays |
US20030203412A1 (en) * | 2002-04-26 | 2003-10-30 | Aristo Vojdani | Immunoassay for detection of antibodies for molds and mycotoxins |
US20040023207A1 (en) | 2002-07-31 | 2004-02-05 | Hanan Polansky | Assays for drug discovery based on microcompetition with a foreign polynucleotide |
US6696304B1 (en) * | 1999-02-24 | 2004-02-24 | Luminex Corporation | Particulate solid phase immobilized protein quantitation |
US6699670B2 (en) | 2001-03-01 | 2004-03-02 | The Johns Hopkins University | Quantitative assay for the simultaneous detection and speciation of bacterial infections |
WO2004054359A2 (fr) | 2002-12-13 | 2004-07-01 | A.M.C. Chemical S.L. | Biopesticide et formulations |
US20040170981A1 (en) | 2003-02-10 | 2004-09-02 | Mckenney Keith | Real-time polymerase chain reaction using large target amplicons |
US6846631B2 (en) | 2001-09-24 | 2005-01-25 | Syngenta Participations Ag | Detection of Fusarium species infecting corn using the polymerase chain reaction |
US6872523B1 (en) | 2000-05-30 | 2005-03-29 | The Board Of Regents Of The University Of Nebraska | Materials and methods for molecular detection of clinically relevant pathogenic fungal species |
US20050176023A1 (en) | 2003-08-01 | 2005-08-11 | Dynal Biotech Inc. | Self-hybridizing multiple target nucleic acid probes and methods of use |
WO2007023461A2 (fr) | 2005-08-26 | 2007-03-01 | Philips Intellectual Property & Standards Gmbh | Methode de detection de micro-organismes et de marqueurs de resistance aux antibiotiques et oligonucléotides d'acides nucleiques a cet effet |
US20080014582A1 (en) | 2006-04-01 | 2008-01-17 | Hooper Dennis G | Methods and compositions for detecting fungi and mycotoxins |
US20080108905A1 (en) | 2002-09-20 | 2008-05-08 | Cprx, Llc | System for sensing, diagnosing and treating physiological conditions and methods |
US7384622B2 (en) | 2004-08-31 | 2008-06-10 | National Institute Of Advanced Industrial Science And Technology | Zeolite nano-crystal suspension, zeolite nano-crystal production method, zeolite nano-crystal suspension production method, and zeolite thin film |
US20100068718A1 (en) | 2008-08-22 | 2010-03-18 | Hooper Dennis G | Methods and Compositions for Identifying Yeast |
US20100075322A1 (en) | 2008-08-22 | 2010-03-25 | Hooper Dennis G | Methods and Compositions for Identifying Mycotoxins and Fungal Species |
US20100129821A1 (en) | 2008-11-26 | 2010-05-27 | Fred Hutchinson Cancer Research Center | Broad range pcr-based compositions and methods for the detection and identification of fungal pathogens |
US20110104684A1 (en) | 2009-10-08 | 2011-05-05 | Hooper Dennis G | Methods and Compositions for Identifying Sulfur and Iron Modifying Bacteria |
US20140221504A1 (en) | 2013-02-06 | 2014-08-07 | Medical Service Consultation International Llc | Methods And Compositions For Detecting Aspergillus Terreus, Aspergillus Niger, And Mycotoxins |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3940598A1 (de) | 1989-12-08 | 1991-06-13 | Behringwerke Ag | Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4835100A (en) * | 1986-10-31 | 1989-05-30 | Neogen Corporation | Method and test kit for detecting an aflatoxin B1 and G1 using novel monoclonal antibodies |
CA2172963C (fr) | 1993-09-29 | 2007-09-11 | Reuben Matalon | Gene de l'aspartoacylase, proteine, et procedes de depistage de mutations associees a la maladie de canavan |
US5922855A (en) | 1993-12-17 | 1999-07-13 | Oregon Health Sciences University | Mammalian DNA mismatch repair genes MLH1 and PMS1 |
US5707802A (en) | 1995-01-13 | 1998-01-13 | Ciba Corning Diagnostics Corp. | Nucleic acid probes for the detection and identification of fungi |
US6218529B1 (en) | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
DE69737125T3 (de) | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
WO1999020752A1 (fr) | 1997-10-21 | 1999-04-29 | The University Court Of The University Of Glasgow | JMY QUI EST UN COACTIVATEUR DE p300/CBP, ACIDE NUCLEIQUE CODANT JMY ET LEURS UTILISATIONS |
US20040166492A1 (en) | 2002-02-05 | 2004-08-26 | Engel Stacia R. | Quantitative detection of dekkera and saccharomyces |
DE60333035D1 (de) | 2002-12-23 | 2010-07-29 | Vical Inc | Impfstoffe gegen infektionen mit dem humanen zytomegalivirus auf grundlage von codonoptimierten polynukleotiden |
US20050233314A1 (en) | 2003-06-30 | 2005-10-20 | National Health Research Institutes | Sensitive and quantitative detection of pathogens by real-time nested PCR |
PE20060789A1 (es) | 2004-10-22 | 2006-08-10 | Biosigma Sa | Cepa de bacteria wenelen dsm 16786 y proceso de lixiviacion basado en la inoculacion de dicha cepa |
US8497113B2 (en) | 2006-02-06 | 2013-07-30 | Jx Nippon Mining & Metals Corporation | Chloride ion-resistant sulfur-oxidizing bacteria |
JP5077984B2 (ja) | 2006-06-29 | 2012-11-21 | 独立行政法人産業技術総合研究所 | 穀類又はナッツ類の流通過程におけるマイコトキシン汚染を予測する方法 |
CZ302670B6 (cs) | 2009-04-21 | 2011-08-24 | Masarykova Univerzita | Zpusob diagnostiky invazivní aspergilózy a oligonukleotidy pro použití pri tomto zpusobu |
MY153040A (en) | 2009-08-27 | 2014-12-31 | Alltech Inc | Synthetic mycotoxin adsorbents and methods of making and utilizing the same |
WO2014197607A1 (fr) | 2013-06-05 | 2014-12-11 | The Regents Of The University Of California | Détection de maladies transmises par les tiques |
IL227374B (en) | 2013-07-08 | 2018-11-29 | Michael Schlosser | Aids for providing acupuncture treatment and other healing procedures |
CA2998873A1 (fr) | 2015-09-17 | 2017-03-23 | Advatect Diagnostics, Llc | Procedes et compositions pour detecter des mycotoxines |
-
2007
- 2007-03-30 WO PCT/US2007/008249 patent/WO2008051285A2/fr active Application Filing
- 2007-03-30 US US11/731,674 patent/US9182398B2/en active Active
-
2012
- 2012-11-06 US US13/669,579 patent/US8628928B2/en active Active
-
2013
- 2013-03-14 US US13/827,441 patent/US20130183697A1/en not_active Abandoned
-
2014
- 2014-04-18 US US14/256,269 patent/US9103829B2/en active Active
-
2015
- 2015-07-01 US US14/789,164 patent/US20150337396A1/en not_active Abandoned
-
2016
- 2016-05-02 US US15/144,016 patent/US10274493B2/en active Active
-
2017
- 2017-06-28 US US15/635,807 patent/US10036748B2/en active Active
-
2018
- 2018-06-13 US US16/007,504 patent/US20190101534A1/en not_active Abandoned
- 2018-08-29 US US16/116,032 patent/US20190101535A1/en not_active Abandoned
-
2019
- 2019-03-22 US US16/361,720 patent/US20190277848A1/en not_active Abandoned
-
2022
- 2022-10-26 US US18/049,993 patent/US20230194523A1/en active Pending
Patent Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4906452A (en) | 1985-10-17 | 1990-03-06 | Neorx Corporation | Trichothecene conjugates and methods of use |
US4744981A (en) | 1985-10-17 | 1988-05-17 | Neorx Corporation | Trichothecene antibody conjugates |
US4772551A (en) | 1985-12-26 | 1988-09-20 | Neogen Corporation | Method and test kit for detecting a trichothecene using novel monoclonal antibodies |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5776694A (en) | 1990-10-19 | 1998-07-07 | Becton Dickinson Company | Diagnostic kits useful for selectively detecting microorganisms in samples |
US5261394A (en) | 1991-09-30 | 1993-11-16 | Triangle Research And Development Corporation | Percussive aid for the treatment of chronic lung disease |
US6345025B1 (en) | 1993-04-12 | 2002-02-05 | Olympus Optical Co., Ltd. | Apparatus for recording and/or reproducing information and/or from optical information record disk |
US5426027A (en) | 1993-05-20 | 1995-06-20 | The Government Of The United States Of America As Represented By The Secretary | Nucleic acid probes and methods for detecting Candida DNA cells in blood |
WO1996021741A1 (fr) | 1995-01-13 | 1996-07-18 | Chiron Diagnostics Corporation | Sondes d'acide nucleique pour la detection et l'identification de champignons |
US6372430B1 (en) | 1997-05-02 | 2002-04-16 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleic acids for detecting Aspergillus species and other filamentous fungi |
US20030129600A1 (en) | 1997-05-02 | 2003-07-10 | Dept. Of Health & Human Ser., C/O Ctr. For Disease Control & Prevention, Ofc. Of Technology Transfer | Nucleic acids for detecting Aspergillus species and other filamentous fungi |
WO1998050584A2 (fr) | 1997-05-02 | 1998-11-12 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, c/o Centers for Disease Control and Prevention, Technology Transfer Offic | Acides nucleiques pour la detection du genre aspergillus et autres champignons filamenteux |
US6362008B1 (en) | 1997-12-23 | 2002-03-26 | Barbara A. Kohn | Generic signalling mechanism for detection of analytes |
US6268222B1 (en) | 1998-01-22 | 2001-07-31 | Luminex Corporation | Microparticles attached to nanoparticles labeled with flourescent dye |
US6696304B1 (en) * | 1999-02-24 | 2004-02-24 | Luminex Corporation | Particulate solid phase immobilized protein quantitation |
US20010004813A1 (en) | 1999-05-28 | 2001-06-28 | Hedman David E. | System and method for removing harmful organic substances from an enclosure |
EP1215282A1 (fr) * | 1999-09-07 | 2002-06-19 | Kyowa Medex Co., Ltd. | Procede de detection de mycotoxines de trichothecene et leur reactif |
US6210345B1 (en) | 1999-10-04 | 2001-04-03 | American Biosystems, Inc. | Outcome measuring airway resistance diagnostic system |
WO2001054653A1 (fr) | 2000-01-28 | 2001-08-02 | Merck Patent Gmbh | Formulation galenique |
US6872523B1 (en) | 2000-05-30 | 2005-03-29 | The Board Of Regents Of The University Of Nebraska | Materials and methods for molecular detection of clinically relevant pathogenic fungal species |
US20030054356A1 (en) | 2000-09-21 | 2003-03-20 | Jacobson James W. | Multiple reporter read-out for bioassays |
US6699670B2 (en) | 2001-03-01 | 2004-03-02 | The Johns Hopkins University | Quantitative assay for the simultaneous detection and speciation of bacterial infections |
US6846631B2 (en) | 2001-09-24 | 2005-01-25 | Syngenta Participations Ag | Detection of Fusarium species infecting corn using the polymerase chain reaction |
US20030203412A1 (en) * | 2002-04-26 | 2003-10-30 | Aristo Vojdani | Immunoassay for detection of antibodies for molds and mycotoxins |
US20040023207A1 (en) | 2002-07-31 | 2004-02-05 | Hanan Polansky | Assays for drug discovery based on microcompetition with a foreign polynucleotide |
US20080108905A1 (en) | 2002-09-20 | 2008-05-08 | Cprx, Llc | System for sensing, diagnosing and treating physiological conditions and methods |
WO2004054359A2 (fr) | 2002-12-13 | 2004-07-01 | A.M.C. Chemical S.L. | Biopesticide et formulations |
US20040170981A1 (en) | 2003-02-10 | 2004-09-02 | Mckenney Keith | Real-time polymerase chain reaction using large target amplicons |
US20050176023A1 (en) | 2003-08-01 | 2005-08-11 | Dynal Biotech Inc. | Self-hybridizing multiple target nucleic acid probes and methods of use |
US7384622B2 (en) | 2004-08-31 | 2008-06-10 | National Institute Of Advanced Industrial Science And Technology | Zeolite nano-crystal suspension, zeolite nano-crystal production method, zeolite nano-crystal suspension production method, and zeolite thin film |
WO2007023461A2 (fr) | 2005-08-26 | 2007-03-01 | Philips Intellectual Property & Standards Gmbh | Methode de detection de micro-organismes et de marqueurs de resistance aux antibiotiques et oligonucléotides d'acides nucleiques a cet effet |
US20130059307A1 (en) | 2006-04-01 | 2013-03-07 | Medical Service Consultation International, Llc | Methods And Compositions For Detecting Fungi And Mycotoxins |
US20080014582A1 (en) | 2006-04-01 | 2008-01-17 | Hooper Dennis G | Methods and compositions for detecting fungi and mycotoxins |
WO2008051285A2 (fr) | 2006-04-01 | 2008-05-02 | Medical Service Consultation International, Llc | Procédés et compositions de détection de champignons et de mycotoxines |
US20140342927A1 (en) | 2006-04-01 | 2014-11-20 | Medical Service Consultation International Llc | Methods and compositions for detecting fungi and mycotoxins |
US8628928B2 (en) | 2006-04-01 | 2014-01-14 | Medical Service Consultation International, Llc | Methods and compositions for detecting fungi and mycotoxins |
US20130183697A1 (en) | 2006-04-01 | 2013-07-18 | Medical Service Consultation International Llc | Methods And Compositions For Detecting Fungi And Mycotoxins |
US20100068718A1 (en) | 2008-08-22 | 2010-03-18 | Hooper Dennis G | Methods and Compositions for Identifying Yeast |
US20100075322A1 (en) | 2008-08-22 | 2010-03-25 | Hooper Dennis G | Methods and Compositions for Identifying Mycotoxins and Fungal Species |
US20100129821A1 (en) | 2008-11-26 | 2010-05-27 | Fred Hutchinson Cancer Research Center | Broad range pcr-based compositions and methods for the detection and identification of fungal pathogens |
US20110104684A1 (en) | 2009-10-08 | 2011-05-05 | Hooper Dennis G | Methods and Compositions for Identifying Sulfur and Iron Modifying Bacteria |
US8962251B2 (en) | 2009-10-08 | 2015-02-24 | Medical Service Consultation International, Llc | Methods and compositions for identifying sulfur and iron modifying bacteria |
US20140221504A1 (en) | 2013-02-06 | 2014-08-07 | Medical Service Consultation International Llc | Methods And Compositions For Detecting Aspergillus Terreus, Aspergillus Niger, And Mycotoxins |
US8956821B2 (en) | 2013-02-06 | 2015-02-17 | Medical Service Consultation International, Llc | Methods and compositions for detecting Aspergillus terreus, Aspergillus niger, and mycotoxins |
Non-Patent Citations (48)
Title |
---|
Ahern, The Scientist, 1995; 20(15):1-9. |
Andersson et al., Appl Environ Microbiol, 1997, 63(2): 387-393. |
Bata et al., Appl Environ Microbiol, Mar. 1985, 49(3): 678-681. |
Bennett et al., "Mycotoxins," Clin. Microbiol. Rev., 2003; 16(3):497-516. |
Bialek et al., "PCR based identification and discrimination of agents of mucomycosis and aspergillosis in paraffin wax embedded tissue," J. Clin. Pathol., 2005; 58:1180-1184. |
Brasel at el., Archives of Environmental Health: An international Journal, Jun. 2004, 59(6): 317-323. |
Brasel et al, "Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia," Applied and Environmental Microbiology, 2005; 71:114-122. |
Brasel et al., (Archives of Environmental Health: An International Journal. Jun. 2004. vol. 59(6):317-323). * |
Brasilerio et al., "Genetic variability within Fusarium solani specie as revealed by PCR-fingerprinting based on pcr markers," Brazilian Journal of Microbiology, 2004, 35: 205-210. |
Chen et al., Identification of Medically Important Yeasts Using PCR-Based Detection of DNA Sequence Polymorphisms in the Internal Transcribed Spacer 2 Region of the rRNA Genes, Journal of Clinical Microbiology, Jun. 2000, p. 2302-2310 (9 pages). |
Cruz-Perez et al., Detection and quantitation of Aspergillus fumigatus in pure culture using polymerase chain reaction, Molecular and Cellular Probes, 2001; 15:81-88. |
De Aguirre et al., Journal of Clinical Microbiology, 2004, 42(8): 3495-3504. |
De Vries et al. "Aspergillus vadensis, a new species of the group of black Aspergilli," Antoine Van Leeuwenhoek, 2005; 87(3): 195-203. |
Ferns, "Evaluation of the role of real-time PCR in the diagnosis of invasive aspergillosis," Leukemia & Lymphoma, 2006; 41(1): 15-20. |
Fontelo et al., (Applied and Environmental Microbio. 1983. vol. 45(2): 640-643). * |
Fox et al., "Detection of Aspergillus fumigatus mycotoxins: immunogen synthesis and immunoassay development," Journal of Microbiological Methods, 2004; 6+: 221-230. |
GenBank AF 138287 [online] Apr. 11, 2000 [retrieved Sep. 20, 2014] retrieved from http://www.ncbi.nlm.nih.gov/nuccore/af138287. |
GenBank AF138288 [online] Apr. 11, 2000 [retrieved on Feb. 23, 2012] retrieved from http://www.ncbi.nlm.nih.gov/nuccore/af138288. |
Gregory et al., Toxicology Pathol., 2004, 32: 26-34. |
Groopman et al., (P.N.A.S. 1984. vol. 81, pp. 7728-7731). * |
Haugland et al., "Identification of putative sequence specific PCR primers for detection of the toxigenic fungal species Stachybotrys chartarum," Mol Cell Probes, Dec. 1998, 12(6): 387-96. |
Henry et al., Identification of Aspergillus Species Using Internal Transcribed Spacer Regions 1 and 2, Journal of Clinical Microbiology, Apr. 2000, p. 1510-1515 (6 pages). |
Hinrikson et al., Journal of Clinical Microbiology, 2005, 43(5): 2092-2103. |
International Search Report and the Written Opinion of the International Searching Authority dated Oct. 17, 2008 filed in related International Application No. PCT/US07/0824921, filed Mar. 30, 2007 (21 pages). |
Kierek-Jaszcuk et al., (Food and Agricultural Immunology. 1995. vol. 7(3):243-252). * |
Koster et al., A Geographically Diverse Set of Isolates Indicates Two Phylogenetic Lineages Within Strachybotrys Chartarum, Can. J. Bot. 81: 633-643, 2003 (10 pages). |
Lee et al., (J. Assoc. Off. Anal. Chem. vol. 1989. 72. No. 2: 345-348). * |
Lee et al., J. Agric. Food Chem., 1990, 38: 444-448. |
Lewis et al., "Detection of gliotoxin in experimental and human aspergillosis," Infection and Immunity; 2005; 73(1): 635-637. |
Llobet-Brossa et al., Aquatic Microbial Ecol, 2002, 29: 211-226. |
Mackay et al., "Real-time PCR in the microbiology laboratory," Clin. Microbiol. Infect, 2004, 10: 190-212. |
McCormick et al., Toxins, 2011, 3: 802-814. |
Nielsen et al., "Yeast populations associated with Ghanaian cocoa fermentations analyzed using denaturing gradient gel electrophoresis (DGGE)," Yeast; 2005; 22:271-284. |
Niesters, et al., Rapid, Polymerase Chain Reaction-Based Identification Assays for Candida Species, Journal of Clinical Microbiology, Apr. 1993, p. 904-910 (7 pages). |
QuantiTox Kit from EviroLogix (Jul. 12, 2004). |
Quatrini et al., Hydrometallurgy, 2006, 83: 263-272. |
Spiess et al., "Development of a LightCycler PCR assay for detection and qualification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients," Journal of Clinical Microbiology, 2003; 41(5): 1811-1818. |
Stack et al., "Nonribosomal peptide synthesis in Apergillus fumigates and other fungi," Microbiology, 2007; 153(5): 1297-1306. |
Suga et al., "Phylogenetic analysis of the phytopathogenic fungus Fusarium solani cased on the rDNA-ITS region," Mycological Research, 2000, 104(10): 1175-1183. |
U.S. Appl. No. 14/590,151, unpublished. |
U.S. Appl. No. 14/590,173, unpublished. |
Vetro (PhD. Thesis: Development of sensitive immunodiagnostics for determination of toxic residues (mycotoxins, drugs) in biological fluids and animal feeds. 2002). * |
Wei et al., Anal Biochem., Feb. 1987, 160(2): 399-408. |
Willinger et al., Journal of Clinical Microbiology, 2003, 41(2): 581-585. |
Wulf-Durand et al., Appl. Environ. Microbiol., 1997, 63(7): 2944-2948. |
Yamanaka, Biochemistry and Environmental Biology: Chemolitho-autotrophic Bacteria, 2008, pp. 7-9. |
Zinkevich et al., FEMS Microbiology Ecology, 2000, 34: 147-155. |
Zorgani et al,., "Detection pyrogenic toxin of Staphylococcus aureus in sudden infant death syndrome," FEMS Immunology and Medical Microbiology, 1999; 25: 103-108. |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10036748B2 (en) | 2006-04-01 | 2018-07-31 | Advatect Diagnostics, Llc | Methods and compositions for detecting fungi and mycotoxins |
US10274493B2 (en) | 2006-04-01 | 2019-04-30 | Advatect Diagnostics, Llc | Methods and compositions for detecting fungi and mycotoxins |
US10030278B2 (en) | 2008-08-22 | 2018-07-24 | Advatect Diagnostics, Llc | Methods and compositions for identifying yeast |
US10793920B2 (en) | 2008-08-22 | 2020-10-06 | Mycodart, Inc. | Methods and compositions for identifying yeast |
US10443106B2 (en) | 2009-10-08 | 2019-10-15 | Advatect Diagnostics, Llc | Methods and compositions for identifying sulfur and iron modifying bacteria |
Also Published As
Publication number | Publication date |
---|---|
US20190101535A1 (en) | 2019-04-04 |
US20130183697A1 (en) | 2013-07-18 |
US20150337396A1 (en) | 2015-11-26 |
US20190101534A1 (en) | 2019-04-04 |
US20190277848A1 (en) | 2019-09-12 |
US9103829B2 (en) | 2015-08-11 |
US20140342927A1 (en) | 2014-11-20 |
US20160313329A1 (en) | 2016-10-27 |
WO2008051285A2 (fr) | 2008-05-02 |
US20230194523A1 (en) | 2023-06-22 |
US10274493B2 (en) | 2019-04-30 |
US20080014582A1 (en) | 2008-01-17 |
US20130059307A1 (en) | 2013-03-07 |
US8628928B2 (en) | 2014-01-14 |
WO2008051285A3 (fr) | 2009-04-02 |
US10036748B2 (en) | 2018-07-31 |
US20170336410A1 (en) | 2017-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230194523A1 (en) | Methods and compositions for detecting fungi and mycotoxins | |
US20220170931A1 (en) | Methods and compositions for detecting mycotoxins | |
US20100075322A1 (en) | Methods and Compositions for Identifying Mycotoxins and Fungal Species | |
US10793920B2 (en) | Methods and compositions for identifying yeast | |
US9150934B2 (en) | Methods and compositions for detecting Aspergillus terreus, Aspergillus niger, and mycotoxins | |
Mendonca et al. | Fungal infections diagnosis–past, present and future | |
WO2008122310A1 (fr) | Procédé de détection d'un analyte dans une matrice biologique | |
Vabret et al. | Comparison of three non-nested RT-PCR for the detection of influenza A viruses | |
US20200299788A1 (en) | Methods and compositions for identifying and quantifying microbial dna | |
US20120107809A1 (en) | Method for simultaneously detecting histoplasma capsulatum and paracoccidioides brasiliensis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDICAL SERVICE CONSULTATION INTERNATIONAL, LLC, T Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOOPER, DENNIS G;REEL/FRAME:019542/0409 Effective date: 20070424 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: ADVATECT DIAGNOSTICS, LLC, TEXAS Free format text: CHANGE OF NAME;ASSIGNOR:MEDICAL SERVICE CONSULTATION INTERNATIONAL, L.L.C.;REEL/FRAME:043026/0923 Effective date: 20170417 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: 7.5 YR SURCHARGE - LATE PMT W/IN 6 MO, SMALL ENTITY (ORIGINAL EVENT CODE: M2555); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: RTL PURCHASER LLC, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ADVATECT DIAGNOSTICS, LLC;REEL/FRAME:066874/0772 Effective date: 20240318 |